Navigation Links
SpideRX® Embolic Protection Device

ProductsSpideRX® Embolic Protection Device
Company ev3, Inc.
Item SpideRX® Embolic Protection Device
Features 
  • Pre-Loaded Filter/Capture Wire - Ready to flush and deploy with no stylet or introducer needed
  • Fully Rapid Exchange - For quick delivery and recovery
  • 6 Fr Guide Catheter Compatible (minimum 0.066" I.D.) - To use with desired interventional devices
  • Use of Separate Preferred 0.014" - 0.018" Guidewire - Reliable access and tight lesion crossing in straight and tortuous anatomy
  • Single Dual-Ended Low-Profile Catheter - Fewer components to manage during procedure
  • Low 3.2 Fr Crossing profile - Minimal interaction with the lesion during catheter placement
  • Unique Nitinol Filter Design - Provides full body wall apposition, and the ability to capture debris
  • Multiple Filter Sizes (3.0, 4.0, 5.0, 6.0, 7.0 mm) - Optimal matching of the filter to the vessel size
  • Longitudinal/Rotational Wire Movement - Filter designed to remain stationary during the intervention and device exchanges
  • Radiopaque Gold Proximal Marker - Visualization of filter apposition throughout intervention
  • 4.2 Fr Recovery Catheter - Easily accommodates filter with debris
  • Rapid Exchange Recovery Catheter - For easy recovery after intervention
Description The SpideRX Embolic Protection Device features the ability to use a separate, preferred guidewire to cross the lesion and a pre-loaded nitinol filter with a dual-ended catheter for delivery and recovery. Offering a fully rapid exchange system, the SpideRX Device is easy to use in the indicated applications:

Carotid Indication - The SpideRX Embolic Protection Device is indicated for use as a guidewire and embolic protection system to contain and remove embolic material (thrombus/debris) while performing angioplasty and stenting procedures in carotid arteries. The diameter of the artery at the site of filter basket placement should be between 3.0 mm and 7.0 mm.

SVG Indication - The SpideRX Embolic Protection Device is indicated for use as an embolic protection system to contain and remove embolic material (thrombus/debris). The device also acts as the guidewire while performing percutaneous transluminal coronary angioplasty or stenting procedures in coronary saphenous vein bypass grafts with reference vessel diameters of 3.0 to 6.0 mm. The safety and effectiveness of this device as an embolic protection system has not been established in the cerebral and peripheral vasculature.

Info ev3, Inc.
Customer Service: (800) 716-6700
Web site: http://www.ev3.net

Related medicine products :

1. Proxis Embolic Protection System
2. FilterWire EZ Embolic Protection System
3. RX ACCUNET Embolic Protection System
4. Emboshield(R) Embolic Protection System
5. Emboshield BareWire Embolic Protection System
6. Onyx® Liquid Embolic System
7. BD Visitec Eye Protection Products
8. T4 Personal Protection System
9. Qualcraft™ Lead-Free Back-Aid Radiation Protection Apron
10. QualCraft™ Radiation Protection Eyewear -- Metal
11. Radiation Protection Eyewear
The Phoresis is a state-of-the-art digital imaging system which allows scanning and storage of electrophoresis results from any Sebia gel including immunofixation. This system provides benefits to an...
... during laparoscopic surgery, will help reduce many ... and loss of distension due to smoke ... from the patient's cavity. This system is ... evacuator that creates a constant closed loop ...
Inquire...
Inquire...
Medicine Products:
(Date:2/26/2017)... , ... February 26, 2017 , ... ... for entries to the 7th Edition of International Social Design Awards. , ... Professionals, Product Designers, System Designers, Governments and Institutions worldwide with realized projects and ...
(Date:2/26/2017)... Philadelphia, PA (PRWEB) , ... February 26, 2017 , ... ... products and services with Pay-For-Performance B2B Marketing. B2B Sellers will now only pay for ... , Robert Hennessey, the founder of IndustryArchive.Org, said, “Given the new reality that B2B ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... disease (PD) in persons with a specific LRRK2 mutation, according to a study ... Previous studies have provided evidence of a link between pesticides and incidence of ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official ... (ILTM) show in Cannes (France), XO Private has initiated a second print-run of its ... measures almost a metre across when open, weighs in at more than six kilos, ...
(Date:2/24/2017)... ... February 24, 2017 , ... The Smart Machine Age is ... University predict that 47 percent of all jobs in the United States may be ... “successful.” The day of the aggressive know-it-all who steamrolls over colleagues is drawing to ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Following receiving CE Marking in ... s AMAR is a major milestone for the country where the ... ound care market in Israel ... for inclusion in the National Health Basket , Israel ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment ...
(Date:2/24/2017)... and Markets has announced the addition of the "Hemophilia Drugs Price ... ... Analysis and Strategies - 2016, provides drug pricing data and benchmarks in ... What are the key drugs marketed for Hemophilia ... market? What are the unit prices and annual treatment ...
(Date:2/24/2017)... 24, 2017 Medical information groups within ... their self-service capabilities to manage inquiries from external ... New research from consulting leader Best Practices, ... self-service website portals where HCPs can sign on ... of many findings to emerge from the new ...
Breaking Medicine Technology: